retatrutide approval status eli lilly Before FDA Approval? Just Changed the Conversation - On The Pen GLP-1 News Eli Lilly's retatrutide drug, not

P.JiL.NiemoellerE.NguynPascalM

Zepbound (same active ingredient, approved for weight loss) offers self-pay vial options starting at $349 monthly through LillyDirect, which may be more affordable than Mounjaro for weight loss purposes

BlueWater's GLP-1 program was differentI wasn't hungry, wasn't struggling

A single 5mg vial covers 10-20 weeks of your starting phase

Clinical Highlights of Retatrutide Study: 48-week, double-blind, placebo-controlled Phase 2 trial Results: ~22.8% weight loss (8 mg dose), ~28.2% weight loss (12 mg dose) ~0.9% HbA1c reduction Significant improvements in cardiometabolic risk factors Safety & Tolerability Most common side effects: nausea, vomiting, diarrhea, abdominal discomfort, constipation typically mild to moderate and dose-dependent

In fact, one of the most common side effects of all insulin therapy, including Toujeo, is weight gain